Technology
Live Price
Offline$4.92
+4.68% today
1Y Change
-77.68%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
DNA X, Inc. (SONM) is a Technology stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $4.92 and down 77.7% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of -300.8%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS -300.8%, free cash flow -170.4% with operating margin 0.0% and ROIC -488.3%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SONM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SONM
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SONM Max Drawdown
-91.32%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SONM and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$64.0M
+17.3% YoY
FY Net Income
-$29.9M
+22.5% YoY
Free Cash Flow
-$10.6M
+72.6% YoY
Revenue Growth
-100.0%
EPS Growth
-300.8%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 58M | 94M | 70M | 55M | 64M |
| Gross Profit | 10M | 19M | 12M | 6M | 15M |
| Operating Income | -34M | 513K | -14M | -38M | -29M |
| EBITDA | -30M | 3M | -11M | -36M | -27M |
| Net Income | -34M | -90K | -14M | -39M | -30M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5M | 9M | 13M | 11M | 22M |
| Total Assets | 40M | 56M | 54M | 41M | 50M |
| Total Liabilities | 45M | 34M | 34M | 22M | 22M |
| Shareholder Equity | -6M | 22M | 20M | 19M | 28M |
| Total Debt | 0 | 55K | 213K | 214K | 362K |
| Net Debt | -5M | -9M | -13M | -11M | -22M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
11M
+72.6% YoY
Capital Expenditures
11K
+76.1% YoY
Free Cash Flow
11M
+72.6% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
839.6%
Debt / Equity
-0.78x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.